SMS PHARMACEUTICALS LTD.
BSE: 532815
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 206.96-13.0% | 237.95+13.1% | 210.45-13.2% | 242.43+23.7% | 196.05-21.0% | 248.20+43.2% | 173.35-11.9% | 196.75 |
| Other Income | 1.74-32.2% | 2.57-31.4% | 3.75+161.7% | 1.43+141.8% | 0.59-58.4% | 1.42-33.1% | 2.13+63.1% | 1.30 |
| Total Income | 208.71-13.2% | 240.52+12.3% | 214.20-12.2% | 243.86+24.0% | 196.64-21.2% | 249.62+42.2% | 175.48-11.4% | 198.05 |
| EXPENSES | ||||||||
| Expenditure | 180.57-15.4% | 213.48+16.7% | 182.89-12.8% | 209.81+21.4% | 172.78-21.7% | 220.56+44.2% | 152.95-14.1% | 178.11 |
| Tax | 7.01+14.5% | 6.12-23.2% | 7.97-10.6% | 8.91+57.6% | 5.65-33.0% | 8.44+57.5% | 5.36-5.7% | 5.68 |
| PROFIT | ||||||||
| PBT | 28.14+4.1% | 27.05-13.6% | 31.31-8.1% | 34.06+42.7% | 23.86-17.9% | 29.06+29.0% | 22.53+13.0% | 19.94 |
| Net Profit | 21.13+1.0% | 20.92-10.4% | 23.34-7.2% | 25.14+38.1% | 18.21-11.7% | 20.62+20.1% | 17.17+20.4% | 14.26 |
| KEY METRICS | ||||||||
| OPM % | 20.24%+3.48pp | 16.76%-4.05pp | 20.81%+0.85pp | 19.96%+0.14pp | 19.82%+3.16pp | 16.66%+12.33pp | 4.33%+1.58pp | 2.75% |
| NPM % | 10.13%+1.43pp | 8.70%-2.20pp | 10.90%+0.59pp | 10.31%+1.05pp | 9.26%+1.00pp | 8.26%-1.53pp | 9.79%+2.59pp | 7.20% |
| EPS | 2.26-1.3% | 2.29-10.9% | 2.57-8.9% | 2.82+37.6% | 2.05-15.6% | 2.43+19.7% | 2.03+20.8% | 1.68 |
Corporate Events
Board MeetingSMSPHARMA
20264Nov
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗ Board MeetingSMSPHARMA
202629Sep
Board Meeting
The 38th Annual General Meeting of the Company, for the fina…
BSE Filing ↗ Board MeetingSMSPHARMA
20261Aug
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗ Board MeetingSMSPHARMA
202622May
Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗ Board MeetingSMSPHARMA
20248Nov
Board Meeting
Consider and approve the un-audited Financial Results (Stand…
BSE Filing ↗ Board MeetingSMSPHARMA
202429May
Board Meeting
Consider and approve the Audited Financial Statements (Stand…
BSE Filing ↗ Board MeetingSMSPHARMA
20238Nov
Board Meeting
Consider and approve financial results for the Second Quarte…
BSE Filing ↗ Board MeetingSMSPHARMA
20238Aug
Board Meeting
Consider and approve un-audited Financial Results (Standalon…
BSE Filing ↗